AI Agents Engineered for Healthcare & Life Sciences
From clinical trials to patient delivery, Syren's AI agents deliver real-time, risk-aware, and governed solutions, purpose-built for pharmaceutical, medical device, and healthcare organizations.
Improvement in supply chain visibility
On-time fulfillment
Reduction in site stockouts
In batch write-off avoided
AI Agents that run your Life Sciences operations
Manual reviews can hamper every life sciences operation. Syren's AI agents turn them into real-time, governed decisions.
GenieBoost
A Databricks Cross-Industry Genie partner Solution built on autonomous AI agents that answer natural-language questions against your governed data estate.
OTIF-D
An agentic AI Databricks partner solution, already in production with a leading pharma company, cutting manual workload by 85% while adding real-time traceability.
Control Tower
An AI-powered control tower using causal ML and explainable AI root cause analysis, unifying supply chain data with real-time scenario modelling.Â
Agentic AI in Pharma and Life Sciences
Every pharma leader piloting agentic AI is asking the same question: where does an agent actually cut risk, and where does it just add another layer to audit?
Our whitepaper breaks down where agentic AI moves the needle across R&D, manufacturing, and supply chain.
Where Our AI Agents Deliver
Cold Chain
predicts cold-chain excursions 2 hours early, tracks assets via BLE/RFID, and triggers Fit-for-Use actions to prevent stockouts.
Network Optimization
visualizes supplier-to-site material flows with AI risk indicators, disruption simulation, and what-if scenario modelling.
WAVE
an autonomous, margin-first air-to-ocean conversion engine that models cost-versus-speed trade-offs and continuously monitors shipment lanes.
Available to Promise
90% delivery accuracy through near real-time inventory, shipping, and production analysis.
Track & Trace
full inventory visibility at every stage; drove $8M in cost savings for a medical device provider.
Data Governance
aligns operations with global regulatory requirements.
Sustainability Tracker
real-time ESG monitoring, delivering a 10% emissions reduction for a pharma leader.
Inventory Management and Network Optimization
MRP, MPS, and replenishment modeling.
Predictive Maintenance of Assets
predictive agents that anticipate equipment failure before it disrupts a batch.
Protocol Amendment Impact Modelling
models how a protocol change ripples through supply and site operations before it's approved.
Regulatory & Import Compliance AI
flags cross-border regulatory and import risk automatically.
Site Activation & Enrolment Intelligence
accelerates site activation and patient enrolment decisions.
Regulatory Content Moderation AI
reviews regulatory content for compliance before it ships.
85% reduction in manual workload with Syren's OTIF-D
Syren + Databricks GenAI partner solution OTIF-D cut manual effort and delivered real-time traceability and decision-ready insights for a leading pharma company.
Value Delivered
$10M+ in Savings with 15% Higher Throughput
AI-driven scheduling helped a global medical device manufacturer reduce changeovers and improve production efficiency.
$8M in Cost Savings from Real-Time Tracking
Track & Trace improved medical device visibility while reducing infrastructure costs by 21%.
10% Reduction in Pharmaceutical Emissions
A sustainability tracker improved emissions visibility and enabled smarter logistics decisions.
90% Delivery Prediction Accuracy
AI-powered planning improved delivery commitments through better inventory and demand intelligence.
Insights
The Risk Detection Gap That’s Costing Pharma Billions
An agentic AI compliance engine for pharma: architecture and integrationÂ
Pharma Supply Chain Complexity and How Agentic AI in Pharma is Solving It
Ready to deploy agentic AI in your life sciences supply chain?
FAQS
Questions teams ask before they start
Life sciences companies using Syren's Agentic AI services have seen a 90% improvement in supply chain visibility, greater than 95% on-time fulfillment, a 20% reduction in site stockouts, and $2M to $5M in batch write-off avoided.